Tag: Stability of Antibody-Based Drugs

How to Conduct Stability Studies for Novel Excipient-Drug Combinations in Compliance with Regulatory Guidelines Stability Testing for Novel Excipient-Drug Combinations: A Regulatory Guide Introduction Novel excipients are substances not previously used in approved drug products, often introduced to enhance formulation properties or delivery of the active drug. Stability testing for drug products containing novel excipient-drug…

Read More “How to Conduct Stability Studies for Novel Excipient-Drug Combinations in Compliance with Regulatory Guidelines” »

How to Address Stability Testing for Drug Products with Multiple Active Ingredients under Regulatory Guidelines Stability Testing for Drug Products with Multiple Active Ingredients: A Regulatory Guide Introduction Drug products with multiple active ingredients, such as combination therapies, require thorough stability testing to ensure that each ingredient remains stable and maintains its intended efficacy and…

Read More “How to Address Stability Testing for Drug Products with Multiple Active Ingredients under Regulatory Guidelines” »

How to Implement ICH Q1A(R2) for Stability Testing in Tropical and Subtropical Regions Stability Testing in Tropical and Subtropical Regions: Applying ICH Q1A(R2) Guidelines Introduction Drug products intended for distribution in tropical and subtropical regions face unique challenges due to high temperatures and humidity levels that can affect their stability. The ICH Q1A(R2) guideline provides…

Read More “How to Implement ICH Q1A(R2) for Stability Testing in Tropical and Subtropical Regions” »

How to Conduct Stability Studies for Drugs with Complex API in Compliance with Regulatory Guidelines Stability Testing for Drugs with Complex APIs: A Regulatory Compliance Guide Introduction Drugs with complex Active Pharmaceutical Ingredients (APIs), such as peptides, proteins, and other large molecules, pose unique challenges in stability testing due to their susceptibility to degradation and…

Read More “How to Conduct Stability Studies for Drugs with Complex API in Compliance with Regulatory Guidelines” »

How to Apply ICH Q10 for Pharmaceutical Quality System in Stability Studies Applying ICH Q10 for Stability Studies: Enhancing Pharmaceutical Quality Systems Introduction ICH Q10, the Pharmaceutical Quality System guideline, provides a comprehensive framework for maintaining and improving the quality of pharmaceutical products throughout their lifecycle. Applying ICH Q10 principles to stability studies helps ensure…

Read More “How to Apply ICH Q10 for Pharmaceutical Quality System in Stability Studies” »

How to Conduct Stability Testing for Modified-Release Formulations in Compliance with Regulatory Guidelines Stability Testing for Modified-Release Formulations: Ensuring Regulatory Compliance Introduction Modified-release formulations, such as extended-release, delayed-release, and controlled-release products, are designed to release their active ingredients over a specific period. Stability testing for these formulations is critical to ensure they maintain their intended…

Read More “How to Conduct Stability Testing for Modified-Release Formulations in Compliance with Regulatory Guidelines” »

How to Implement ICH Q8 for Stability Testing in Pharmaceutical Development Applying ICH Q8 for Stability Testing in Pharmaceutical Development Introduction The ICH Q8 guideline, “Pharmaceutical Development,” emphasizes a systematic approach to development that ensures product quality through design, understanding, and control of manufacturing processes. Implementing ICH Q8 principles in stability testing helps to optimize…

Read More “How to Implement ICH Q8 for Stability Testing in Pharmaceutical Development” »